NCT01225302 2017-11-21
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 1 Completed
Clinical Trials
3 trialsNCT00716534 2013-04-29
Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 2 Completed
NCT00517790 2013-04-05
Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
AbbVie
Phase 2 Completed